Global Blood Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.54%165.720.7%$1351.20m
LLYEli Lilly & Co. 0.99%324.731.1%$1078.25m
ABBVAbbVie, Inc. 1.96%141.031.9%$868.96m
PFEPfizer Inc. 0.52%44.370.9%$802.32m
BMYBristol-Myers Squibb Co. 1.13%71.331.0%$781.43m
MRKMerck & Co., Inc. 0.79%88.240.7%$715.97m
AZNAstraZeneca Plc 2.14%56.741.0%$395.79m
GSKGSK Plc 2.07%30.880.3%$214.02m
ALNYAlnylam Pharmaceuticals, Inc. -1.98%192.908.2%$213.09m
NVSNovartis AG 2.18%78.340.2%$206.05m
IDXXIDEXX Laboratories, Inc. 3.75%349.293.9%$191.19m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.485.4%$191.16m
HZNPHorizon Therapeutics Plc 1.71%65.365.4%$176.62m
ATXIAvenue Therapeutics, Inc. 15.90%13.340.0%$161.45m
SRPTSarepta Therapeutics, Inc. -1.22%108.6012.4%$135.07m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.